Banka BioLoo financials

·UnclassifiedChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹10.6cr−5.3% on Q1 FY26
Net profit
−₹0.0cr₹0.0 cr in Q1 FY26
EBITDA margin
17.2%+14.2 pts on Q1 FY26
EPS
−₹0.01No figure a year before

Quarterly results

Every quarter ›
₹ croreQ1 FY27Q1 FY26Change
Revenue10.611.1−5.3%
EBITDA1.80.3+430.5%
EBITDA margin17.2%3.1%+14.2 pts
Profit before tax−0.1−0.1—
Net profit−0.00.0—
EPS−₹0.01₹0.00—

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹10.6 crNet profit₹−0.0 crNet margin−0.4%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
68.3————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
10.210.20.20.30.8
3.03.00.10.0—
39.339.334.324.815.0
100————
56.557.154.250.042.3
—+5.4%+8.4%+18.1%—
6.65.2−2.93.65.9
11.8%9.1%−5.3%7.3%14.0%
3.62.4−5.41.44.5
0.40.4−8.9−0.72.5
0.6%0.7%−16.4%−1.3%6.0%
₹0.30₹0.32−₹8.16−₹0.45₹2.32
—+103.9%−1,694.6%−119.6%—
—1.10.92.89.6
—−6.0−4.5−10.0−6.4
−4.9−4.9−3.6−7.23.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BANKA₹62.50

Banka BioLoo Limited

· Unclassified
₹ CrorePeersRAJMETAAKASHGLOBEGRADIENTEMOKSHARTNIRMANAJOONIBEARDSELLMcap ₹68.3 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————68.3
- Cash, Equiv & ST Investments0.80.30.210.210.2
+ Minority Interest—0.00.13.03.0
+ Total Debt15.024.834.339.339.3
Enterprise Value————100.4
Revenue42.350.054.257.156.5
Growth %, YoY—+18.1+8.4+5.4—
EBITDA5.93.6-2.95.26.6
Margin %14.047.25-5.309.1011.75
EBIT4.51.4-5.42.43.6
Net Income2.5-0.7-8.90.40.4
Margin %6.00-1.34-16.440.690.62
EPS, Adj (current shares)2.32-0.45-8.160.320.30
Growth %, YoY—-119.6-1,694.6+103.9—
Cash from Operations9.62.80.91.1—
Capital Expenditures-6.4-10.0-4.5-6.0—
Free Cash Flow3.2-7.2-3.6-4.9-4.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Banka BioLoo financials and key ratios

Prices at the 30 October 2026 close · figures from the company's filings with NSE

Banka BioLoo (NSE: BANKA) had a market capitalisation of ₹67.2 crore at the 30 October 2026 close (₹61.46 a share), a PE ratio of 201.9 on the last four quarters' profit and a price-to-book ratio of 1.70. In FY26 its consolidated net profit was ₹35 lakh on revenue of ₹57.1 crore; in Q1 FY27 (April–June 2026) it was a loss of ₹1.3 lakh. Its debt-to-equity ratio was 0.92 on 31 March 2026. Promoters held 52.02% of the shares on 30 September 2026.

Banka BioLoo Q1 FY27 results
filed 13 August 2026
Share price used
₹61.46 · 30 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Banka BioLoo at a glance · consolidated

Market cap
₹67.2 Crat ₹61.46 · 30 Oct close
PE ratio (last 4 quarters)
201.9191.2 on FY26 profit
Price to book (PB)
1.70book value ₹36.18 a share
ROE (FY26)
1.0%+26.0 pts vs FY25ROCE 4.7%
Debt to equity
0.92net debt ₹28.3 Cr
Promoter holding
52.02%unchanged vs 30 Jun 202630 September 2026
Net worth
₹39.6 Cr+25.5% vs 31 Mar 202531 March 2026
Free cash flow (FY26)
−₹4.9 Cr
EPS (FY26)
₹0.32

Questions

What is the Banka BioLoo PE ratio today?

Banka BioLoo's PE ratio is 201.9 at the 30 October 2026 close (₹61.46 a share): a market capitalisation of ₹67.2 crore divided by consolidated net profit of ₹33 lakh over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹35 lakh) it is 191.2. These four quarters include net exceptional items of −₹30 lakh (one-off charges reported separately), so the ratio on recurring profit would differ.

What is the Banka BioLoo PB ratio (price to book value)?

Banka BioLoo's price-to-book (PB) ratio is 1.70 at the 30 October 2026 close: a market capitalisation of ₹67.2 crore divided by shareholders' equity (book value) of ₹39.6 crore on 31 March 2026. That is a book value of ₹36.18 per share against a share price of ₹61.46.

What is the Banka BioLoo ROE and ROCE?

In FY26, Banka BioLoo's return on equity (ROE) was 1.0% and its return on capital employed (ROCE) was 4.7%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was −25.0% and ROCE −11.2%.

What is the Banka BioLoo market cap?

Banka BioLoo's market capitalisation was ₹67.2 crore at the 30 October 2026 close: 1.09 crore shares at ₹61.46 each.

Is Banka BioLoo debt free?

No. Banka BioLoo had borrowings of ₹39.3 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.92. Its cash and current investments were ₹11 crore, so its net debt was ₹28.3 crore.

What is the Banka BioLoo EPS?

Banka BioLoo's basic earnings per share (EPS) were ₹0.32 in FY26. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹0.30.

What is the Banka BioLoo debt to equity ratio?

Banka BioLoo's debt-to-equity ratio was 0.92 on 31 March 2026: borrowings of ₹39.3 crore against total equity of ₹42.6 crore. A year earlier, on 31 March 2025, it was 1.08.

What is the Banka BioLoo promoter holding?

Promoters held 52.02% of Banka BioLoo on 30 September 2026, unchanged from the previous quarter and down 0.21 percentage points from 52.23% a year earlier, according to the shareholding pattern filed with NSE.

When are the Banka BioLoo next results?

Banka BioLoo has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.

What is the Banka BioLoo net worth?

Banka BioLoo's net worth — shareholders' equity in its consolidated balance sheet — was ₹39.6 crore on 31 March 2026, up 25.5% from ₹31.5 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹67.2 crore at the 30 October 2026 close.

What is the Banka BioLoo book value per share?

Banka BioLoo's book value per share was ₹36.18 on 31 March 2026: shareholders' equity of ₹39.6 crore divided by the 1.09 crore shares in issue, up 24.9% from ₹28.98 a year earlier. The share price at the 30 October 2026 close was ₹61.46.

What is the Banka BioLoo shareholding pattern?

On 30 September 2026, Banka BioLoo's shares were held by promoters 52.02%, foreign portfolio investors (FII/FPI) 0.00%, domestic institutions (DII) 0.00% (including mutual funds at 0.00%) and retail and other non-institutional investors 47.98%.

What is the Banka BioLoo free cash flow?

In FY26, Banka BioLoo generated ₹1.1 crore of cash from operations and spent ₹6 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹4.9 crore. In FY25 it was −₹3.6 crore.

What are the Banka BioLoo latest quarterly results?

Banka BioLoo's latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net loss ₹1.3 lakh, against a profit of ₹0.5 lakh in Q1 FY26; revenue from operations ₹10.6 crore, down 5.3% year on year.

What is the Banka BioLoo revenue and profit in FY26?

In FY26 (April 2025–March 2026), Banka BioLoo's consolidated net profit was ₹35 lakh, against a loss of ₹8.9 crore in FY25, on revenue from operations of ₹57.1 crore (up 5.4%). Over three years, from FY23, net profit was down 86.2%.

How does Banka BioLoo compare with its peers?

On FY26 consolidated figures, against Rajnandini Metal and GLOBE ENTERPRISES: Banka BioLoo's operating margin of 4.2% is the second highest of the three (Rajnandini Metal 0.7%, GLOBE ENTERPRISES 4.3%; peer average 2.5%); its return on equity of 1.0% is the second highest of the three (Rajnandini Metal −0.6%, GLOBE ENTERPRISES 6.3%; peer average 2.8%).

Banka BioLoo vs Rajnandini Metal: how do they compare?

In FY26, Banka BioLoo earned net profit of ₹35 lakh on revenue of ₹57.1 crore, against ₹32 lakh on ₹263 crore for Rajnandini Metal. Banka BioLoo's operating margin was 4.2% (Rajnandini Metal 0.7%) and its return on equity 1.0% (Rajnandini Metal −0.6%). At the 30 October 2026 close, Banka BioLoo's market capitalisation was ₹67.2 crore against ₹81.3 crore for Rajnandini Metal.

Where do these Banka BioLoo figures come from?

From Banka BioLoo's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.